Cadchem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 29-11-2024
- Paid Up Capital ₹ 2.14 Cr
as on 29-11-2024
- Company Age 39 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.47 Cr
as on 29-11-2024
- Satisfied Charges ₹ 59.33 Cr
as on 29-11-2024
- Revenue 45.29%
(FY 2023)
- Profit 53.80%
(FY 2023)
- Ebitda -0.47%
(FY 2023)
- Net Worth 14.17%
(FY 2023)
- Total Assets 21.79%
(FY 2023)
About Cadchem Laboratories
The Corporate was formerly known as Chandigarh Drugs Prive Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.14 Cr.
The company currently has active open charges totaling ₹36.47 Cr. The company has closed loans amounting to ₹59.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kishore Deshmukh, Navneet Gupta, and Neeru Gupta serve as directors at the Company.
- CIN/LLPIN
U24299CH1985PLC006448
- Company No.
006448
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Sep 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cadchem Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navneet Gupta  | Managing Director | 10-Feb-1997 | Current |
| Neeru Gupta | Managing Director | 20-Apr-1990 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kishore Deshmukh | Additional Director | 13-Feb-2024 | Current |
Financial Performance of Cadchem Laboratories.
Cadchem Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.29% increase. The company also saw a substantial improvement in profitability, with a 53.8% increase in profit. The company's net worth Soared by an impressive increase of 14.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cadchem Laboratories?
In 2023, Cadchem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 17 Aug 2022 | ₹5.01 M | Open |
Hdfc Bank Limited Creation Date: 06 Jan 2021 | ₹2.50 M | Open |
Axis Bank Limited Creation Date: 22 Oct 2020 | ₹35.64 Cr | Open |
How Many Employees Work at Cadchem Laboratories?
Cadchem Laboratories has a workforce of 87 employees as of Nov 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cadchem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadchem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
